Cipla and Meda expand alliance for rhinitis combination
This article was originally published in Scrip
Executive Summary
Meda, the Swedish specialty pharma company, and India's Cipla are expanding an existing long-term collaboration for combining azelastine and fluticasone in a nasal formulation for allergic rhinitis.